Recent News for MYL - Mylan Inc.

Date Title
Oct 14 Bernstein sees 19% upside in Amgen in premarket analyst action
Oct 12 Is Mylan N.V. (MYL) A Good Stock To Buy?
Oct 10 Why the Earnings Surprise Streak Could Continue for Mylan (MYL)
Oct 7 Theravance Pipeline Strong, Dependence on Yupelri a Concern
Oct 1 As Buyout Fever Grows, Alexion, Amarion and BioMarin Are Potential Targets
Sep 30 Mylan (MYL) to Pay $30M to Settle SEC Charges for EpiPen
Sep 27 Pharma Giant Mylan To Pay $30 Million To Settle EpiPen Scandal
Sep 27 Mylan will pay $30M to settle charges related to EpiPen probe
Sep 27 SEC fines Mylan $30 million for Epipen disclosure failure
Sep 27 Mylan to Pay $30 Million to Settle SEC Suit Over EpiPen Probe
Sep 27 Mylan Finalizes Previously Disclosed Settlement with U.S. Securities and Exchange Commission
Sep 27 Mylan down on rumored SEC lawsuit
Sep 27 U.S. SEC sues Mylan for concealing possible loss tied to EpiPen
Sep 27 Mylan to Pay $30M to Settle SEC Lawsuit Related to EpiPen Misclassification
Sep 25 How This IBD Stock Of The Day Is Rattling Medical Giants Amgen, Mylan
Sep 24 LabCentral co-founder issues ‘call to action' to biotechs on drug pricing
Sep 21 Stocks To Watch: Amazon, Alibaba And Peloton In Focus
Sep 20 The Opioid Crisis Could Hurt Investors. Here’s How.
Sep 19 J&J's Prostate Cancer Drug Gets FDA Nod for Expanded Use
Sep 19 Pfizer Is Spinning Off Upjohn. What’s Left Will Be No Bargain, Analyst Says
Sep 19 5 Undervalued Stocks to Buy
Sep 17 Mylan Expands Oncology Portfolio with Launch of Generic Faslodex® Injection, a Treatment for Advanced Breast Cancer
Sep 13 FDA alerts on Zantac contamination
Sep 11 Leaner Pfizer Positioned to Boost R&D Output
Sep 10 12 Cheapest Stocks In The S&P 500
Back to the Main MYL Page...